Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
+$661M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$484M |
| 3 |
Amazon
AMZN
|
+$482M |
| 4 |
Netflix
NFLX
|
+$345M |
| 5 |
Pfizer
PFE
|
+$314M |
Top Sells
| 1 |
Apple
AAPL
|
+$900M |
| 2 |
Microsoft
MSFT
|
+$393M |
| 3 |
UnitedHealth
UNH
|
+$388M |
| 4 |
Merck
MRK
|
+$272M |
| 5 |
Bank of America
BAC
|
+$265M |
Sector Composition
| 1 | Technology | 22.26% |
| 2 | Healthcare | 14.77% |
| 3 | Financials | 12.79% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
ANI Pharmaceuticals
ANIP
$2.14B
| $2.4M | ﹤0.01% |
58,846
-3,017
| -5% | -$123K |
|
2102
Washington Trust Bancorp
WASH
$571M
| $2.4M | ﹤0.01% |
65,554
-347
| -0.5% | -$12.7K |
|
2103
Madrigal Pharmaceuticals
MDGL
$9.79B
| $2.39M | ﹤0.01% |
35,852
+2,679
| +8% | +$179K |
|
2104
Par Pacific Holdings
PARR
$1.71B
| $2.39M | ﹤0.01% |
335,962
-197,396
| -37% | -$1.4M |
|
|
AXDX
2105
DELISTED
Accelerate Diagnostics
AXDX
| $2.38M | ﹤0.01% |
28,542
-411
| -1% | -$34.2K |
|
2106
Artivion
AORT
$2B
| $2.38M | ﹤0.01% |
140,353
+4,023
| +3% | +$68.1K |
|
2107
Cross Country Healthcare
CCRN
$415M
| $2.37M | ﹤0.01% |
352,152
+93,786
| +36% | +$632K |
|
2108
Forrester Research
FORR
$191M
| $2.37M | ﹤0.01% |
81,216
-15,885
| -16% | -$464K |
|
2109
Lands' End
LE
$467M
| $2.37M | ﹤0.01% |
444,652
+193,226
| +77% | +$1.03M |
|
2110
Nu Skin
NUS
$579M
| $2.37M | ﹤0.01% |
108,594
-1,696
| -2% | -$37.1K |
|
2111
BGC Group
BGC
$4.84B
| $2.37M | ﹤0.01% |
941,495
+20,330
| +2% | +$51.2K |
|
2112
Goosehead Insurance
GSHD
$2.05B
| $2.37M | ﹤0.01% |
53,046
+10,274
| +24% | +$459K |
|
2113
York Water
YORW
$446M
| $2.37M | ﹤0.01% |
54,426
+1,082
| +2% | +$47K |
|
|
KRA
2114
DELISTED
Kraton Corporation
KRA
| $2.37M | ﹤0.01% |
292,019
+53,971
| +23% | +$437K |
|
2115
American Vanguard Corp
AVD
$159M
| $2.34M | ﹤0.01% |
161,859
-6,268
| -4% | -$90.7K |
|
|
CCF
2116
DELISTED
Chase Corporation
CCF
| $2.33M | ﹤0.01% |
28,302
+442
| +2% | +$36.4K |
|
2117
Surmodics
SRDX
$461M
| $2.32M | ﹤0.01% |
69,638
-33,680
| -33% | -$1.12M |
|
2118
National Research Corp
NRC
$374M
| $2.32M | ﹤0.01% |
51,004
+248
| +0.5% | +$11.3K |
|
2119
Standex International
SXI
$2.52B
| $2.32M | ﹤0.01% |
47,318
+49
| +0.1% | +$2.4K |
|
2120
Great Southern Bancorp
GSBC
$721M
| $2.31M | ﹤0.01% |
57,232
+2,316
| +4% | +$93.6K |
|
2121
National Beverage
FIZZ
$3.78B
| $2.31M | ﹤0.01% |
108,260
+4,716
| +5% | +$101K |
|
|
STFC
2122
DELISTED
State Auto Financial Corp
STFC
| $2.31M | ﹤0.01% |
83,019
+1,346
| +2% | +$37.4K |
|
|
BCEL
2123
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $2.3M | ﹤0.01% |
138,697
+122,797
| +772% | +$2.03M |
|
2124
Nicolet Bankshares
NIC
$2.01B
| $2.29M | ﹤0.01% |
41,914
+2,111
| +5% | +$115K |
|
|
ADAM
2125
Adamas Trust, Inc. Common Stock
ADAM
$654M
| $2.29M | ﹤0.01% |
368,849
+141,147
| +62% | +$875K |
|